[Experience in the use of high-frequency selective percutaneous rhizotomy in @entity4254 associated with XXXX ].

@entity1 @entity4254 @entity15 @entity158
OBJECTIVE: the study was aimed at assessment of the efficacy of percutaneous high frequency selective rhizotomy (PHFSR) after failure of conservative treatment of @entity4254 ( @entity4254 ) in @entity15 ( @entity15 ). MATERIAL AND METHODS: A retrospective analysis of 28 @entity1 with @entity4254 associated with @entity15 who underwent percutaneous rhizotomy in the period from 2000 to 2014 was performed. All @entity1 were definitely diagnosed with @entity15 according to the McDonald criteria (version of 2001, 2005, and 2010). The @entity1 were divided by age, gender, and the trigeminal nerve branches involved in the process. The @entity1 ' condition was evaluated at different times after surgery. RESULTS: Good outcomes in the form of @entity158 syndrome regression were achieved in 100% of the @entity1 . A disease recurrence was observed in 6 (21%) @entity1 during a follow-up period of 3 months to 14 years. Dysesthesia complications occurred in 4 (14%) @entity1 . There were no deaths and severe complications. The percentage of minor complications was low. CONCLUSION: These data confirm that PHFSR is a safe, repeatable, and effective method of symptomatic neurosurgical treatment of @entity4254 associated with @entity15 and may be recommended in the case of failure/intolerance of medication.
